Your browser doesn't support javascript.
loading
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.
Malahleha, Mookho; Laher, Fatima; Dilraj, Athmanundh; Smith, Philip; Gray, Glenda E; Grove, Doug; Odhiambo, Jackline A; Andrasik, Michele P; Grunenberg, Nicole A; Moodie, Zoe; Huang, Yunda; Borate, Bhavesh R; Gillespie, Kevin M; Allen, Mary; Atujuna, Millicent; Singh, Nishanta; Kalonji, Dishiki; Meintjes, Graeme; Kotze, Phillip; Bekker, Linda-Gail; Janes, Holly.
Afiliación
  • Malahleha M; Setshaba Research Centre, Soshanguve, Tshwane, South Africa.
  • Laher F; Synergy Biomed Research Institute, East London, Eastern Cape, South Africa.
  • Dilraj A; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Smith P; Setshaba Research Centre, Soshanguve, Tshwane, South Africa. ADilraj@setshaba.org.za.
  • Gray GE; Setshaba Research Centre, 2088 Block H, Soshanguve, Pretoria, 0152, South Africa. ADilraj@setshaba.org.za.
  • Grove D; The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.
  • Odhiambo JA; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Andrasik MP; South African Medical Research Council, Cape Town, South Africa.
  • Grunenberg NA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Borate BR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gillespie KM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Allen M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Atujuna M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Singh N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Kalonji D; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Meintjes G; The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.
  • Kotze P; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa.
  • Bekker LG; South African Medical Research Council, Cape Town, South Africa.
  • Janes H; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa.
AIDS Behav ; 27(9): 3027-3037, 2023 Sep.
Article en En | MEDLINE | ID: mdl-36929319

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Vacunas contra el SIDA / Minorías Sexuales y de Género Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: AIDS Behav Asunto de la revista: CIENCIAS DO COMPORTAMENTO / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Vacunas contra el SIDA / Minorías Sexuales y de Género Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: AIDS Behav Asunto de la revista: CIENCIAS DO COMPORTAMENTO / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article